In the last couple ofyears, a record number of personalized therapeutic products were approved inthe US, establishing an urgent need for companion diagnostics and causing manydrug developers to actively seek external support and expertise
Roots Analysis is pleased toannounce the publication of its recent study, titled, “CompanionDiagnostics Development ServicesMarket, 2020-2030”
The report features an extensive study of thecurrent market landscape, offering an informed opinion on the likely adoptionof diagnostic development services over the next decade. It features anin-depth analysis, highlighting the capabilities of the various stakeholders inthis domain. In addition to other elements, the study includes:
§ A detailed assessmentof the current market landscape of more than 180 companies offering companiondiagnostics services.
§ Tabulated profiles ofcompanion diagnostics service providers (shortlisted on the basis of the numberof services offered).
§ An analysis of thepartnerships that have been established in this domain, in the recent past.
§ A list of stakeholders generated based on a detailedanalysis of a set of relevant parameters, which are anticipated to partner withcompanion diagnostics services providers in the foreseen future.
§ A detailed competitiveness analysis of companiondiagnostics services providers, featuring insightfulpictorial summaries and representations.
§ A comparativeanalysis of the needs of different stakeholders involved in this domain.
§ A discussion onvarious steps of the development operations of a companion diagnostic and thecost requirements across each of the stages.
§ An analysis ofcompleted, ongoing and planned clinical trials featuring disease-specificbiomarkers.
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
- Type of Services
§ FeasibilityStudies
§ AssayDevelopment
§ AnalyticalValidation
§ ClinicalValidation
§ Manufacturing
- Type of Analytical Technique
§ in situ hybridization/ Immunohistochemistry
§ Next GenerationSequencing
§ Polymerase ChainReaction
§ Others
- Key Geographical Region
§ NorthAmerica
§ Europe
§ Asia-Pacificand the Rest of the World
Transcripts of interviews held with thefollowing senior level representatives of stakeholder companies
§ Anton Iliuk (President, Chief Technology Officer TymoraAnalytical Operations)
§ Paul Kortschak (Senior Vice President, Novodiax)
§ Pablo Ortiz (Chief Executive Officer, OWL Metabolomics)
§ Lawrence M. Weiss (Chief Scientific Officer, NeoGenomicsLaboratories)
Keycompanies covered in the report - https://www.rootsanalysis.com/reports/297/request-sample.html
§ Almac DiagnosticServices
§ Asuragen
§ BARD1 Life Sciences
§ BioMarCareTechnologies
§ Covance
§ Gencurix
§ Geneuity
§ Leica Biosystems
§ Macrogen
§ MD Biosciences
§ R-Biopharm
§ ResearchDx
§ Tepnel PharmaServices
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Other RecentOfferings
1. NeoantigenTargeted Therapies Market, 2019-2030
2. BispecificAntibody Therapeutics Market (4th Edition),2019-2030
3. GlobalStem Cells Market: Focus on ClinicalTherapies, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastestgrowing market research companies, sharing fresh and independent perspectivesin the bio-pharmaceutical industry. The in-depth research, analysis andinsights are driven by an experienced leadership team which has gained manyyears of significant experience in this sector. If you’d like help with yourgrowing business needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
